Article
Etiology and Management of Therapy-Related Myeloid Leukemia
1 Jan 2007
Abstract excerpt
The diagnosis of therapy-related myeloid leukemia (t-MDS/t-AML) identifies a group of high-risk patients with multiple and varied poor prognostic features. These neoplasms are thought to be the direct consequence of mutational events induced by cytotoxic therapy. Their outcomes have historically been poor compared with those of people who develop acute myeloid leukemia (AML) de novo. The question arises whether a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
